Posted in | News | Business

Take Over Offer for Ausmelt

Oct 19 2009

Related Stories

Ausmelt Limited (AET) has received an indicative non-binding expression of interest (Indicative Offer) to acquire all of the shares in Ausmelt.

The Indicative Offer price is significantly in excess of the current share price and the Board recommends that shareholders do not sell or deal in their Ausmelt shares until further update from the Company.

The Indicative Offer is subject to due diligence and the Ausmelt directors are presently undertaking a full evaluation of the proposed terms and conditions. Discussions are ongoing and are presently incomplete.

The Company has appointed corporate advisers M&A Partners and Middletons Lawyers to assist the Ausmelt directors in their consideration of the Indicative Offer. Ausmelt will keep shareholders fully informed on any developments.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback